Hippocampal CD39/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP.

EMBO Reports
Qian-Qian CuiFang Wang

Abstract

Emerging evidence implicates that low levels of ATP in the extracellular space may contribute to the pathophysiology of major depressive disorder (MDD). The concentration of extracellular ATP is regulated by its hydrolase ectonucleotide tri(di)phosphohydrolase (ENTPD). However, the role of ENTPD in depression remains poorly understood. Here we examine the role of CD39 (known as ENTPD1) in mouse depression-like behavior induced by chronic social defeat stress (CSDS). We demonstrate that CSDS enhances the expression and activity of CD39 in hippocampus. The CD39 functional analog apyrase also induces depression-like behavior, which can be ameliorated by ATP replenishment. Pharmacological inhibition and genetic silencing of CD39 has an antidepressant-like effect via increasing hippocampal extracellular ATP concentration, accompanied with an increase in hippocampal neurogenesis and dendritic spine numbers in defeated mice. These results suggest that hippocampal CD39 contributes to CSDS-induced depression-like behavior via hydrolyzing extracellular ATP, indicating that CD39 may be a promising new target for the treatment of depression.

References

Sep 1, 1991·Journal of Neurocytology·R S Cohen, V Kriho
Feb 5, 2002·Annual Review of Physiology·Esther A NimchinskyKarel Svoboda
Jul 10, 2003·Trends in Neurosciences·Haruo KasaiHiroyuki Nakahara
Aug 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K A BuckleyJ A Gallagher
Sep 23, 2003·The Journal of Physiology·William J Tyler, Lucas Pozzo-Miller
Apr 2, 2004·The American Journal of Psychiatry·Stephanie CampbellGlenda M MacQueen
Oct 28, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marta ZagrebelskyMartin Korte
Jan 5, 2006·The American Journal of Psychiatry·Madhukar H TrivediUNKNOWN STAR*D Study Team
Apr 28, 2006·Pflügers Archiv : European journal of physiology·Herbert Zimmermann
Dec 26, 2006·Developmental Biology·Jane H-C LinMaiken Nedergaard
May 15, 2007·Current Opinion in Neurobiology·Jennifer Bourne, Kristen M Harris
Jul 3, 2007·British Journal of Pharmacology·S A LévesqueJ Sévigny
Sep 14, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christopher Pittenger, Ronald S Duman
Jun 16, 2009·Current Opinion in Neurobiology·Yoshihiro YoshiharaDominique Muller
Aug 21, 2009·Nature Reviews. Neuroscience·Anthony Holtmaat, Karel Svoboda
Sep 11, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marta KuberaMichael Maes
Feb 19, 2011·Nature Reviews. Immunology·Wolfgang G Junger
Sep 13, 2011·Progress in Neurobiology·Geoffrey BurnstockPeter Illes
Mar 2, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eun Sun JungInhee Mook-Jung
Apr 5, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yan-Kun LiJian-Guo Chen
Oct 9, 2012·Science·Ronald S Duman, George K Aghajanian
Oct 9, 2012·Science·Amelia J Eisch, David Petrik
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maura BoldriniJ John Mann
Jan 18, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Claudia SchmuckermairNicolas Singewald
May 7, 2013·Nature Medicine·Xiong CaoTian-Ming Gao
Jan 20, 2015·Neuropathology and Applied Neurobiology·Paula Garcia-EsparciaIsidre Ferrer
Apr 3, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexis S HillRené Hen
Jun 30, 2015·The Journal of Clinical Investigation·Yogendra KanthiDavid J Pinsky
Sep 20, 2015·Neuropharmacology·Edward BeamerBeáta Sperlágh
Jan 14, 2016·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eleni SiopiFrançoise Lazarini
Mar 27, 2016·Biological Psychiatry·Naoko Abe-HiguchiYoshifumi Watanabe
May 30, 2016·Trends in Immunology·Maisa C TakenakaFrancisco J Quintana
Jun 18, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yin-Yin BaiXin-Fu Zhou

❮ Previous
Next ❯

Citations

Oct 2, 2020·Nature·Thomas Pfeiffer, David Attwell
Dec 8, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Joana I GomesSandra H Vaz
Jan 1, 2021·International Journal of Molecular Sciences·Thomas Ho-Yin Lee, Suk-Yu Yau
Dec 18, 2020·Biochemical Pharmacology·Cátia R LopesPaula M Canas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Bin ZhangKe Zhao
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
P LiJ Yang
© 2021 Meta ULC. All rights reserved